» Articles » PMID: 11706038

Phosphorylation of Glycogen Synthase Kinase-3 and Stimulation of T-cell Factor Signaling Following Activation of EP2 and EP4 Prostanoid Receptors by Prostaglandin E2

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2001 Nov 14
PMID 11706038
Citations 117
Authors
Affiliations
Soon will be listed here.
Abstract

Recently we have shown that the FP(B) prostanoid receptor, a G-protein-coupled receptor that couples to Galpha(q), activates T-cell factor (Tcf)/lymphoid enhancer factor (Lef)-mediated transcriptional activation (Fujino, H., and Regan, J. W. (2001) J. Biol. Chem. 276, 12489-12492). We now report that the EP(2) and EP(4) prostanoid receptors, which couple to Galpha(s), also activate Tcf/Lef signaling. By using a Tcf/Lef-responsive luciferase reporter gene, transcriptional activity was stimulated approximately 10-fold over basal by 1 h of treatment with prostaglandin E(2) (PGE(2)) in HEK cells that were stably transfected with the human EP(2) and EP(4) receptors. This stimulation of reporter gene activity was accompanied by a PGE(2)-dependent increase in the phosphorylation of both glycogen synthase kinase-3 (GSK-3) and Akt kinase. H-89, an inhibitor of protein kinase A (PKA), completely blocked the agonist-dependent phosphorylation of GSK-3 in both EP(2)- and EP(4)-expressing cells. However, H-89 pretreatment only blocked PGE(2)-stimulated Lef/Tcf reporter gene activity by 20% in EP(4)-expressing cells compared with 65% inhibition in EP(2)-expressing cells. On the other hand wortmannin, an inhibitor of phosphatidylinositol 3-kinase, had the opposite effect and inhibited PGE(2)-stimulated reporter gene activity to a much greater extent in EP(4)-expressing cells as compared with EP(2)-expressing cells. These findings indicate that the activation of Tcf/Lef signaling by EP(2) receptors occurs primarily through a PKA-dependent pathway, whereas EP(4) receptors activate Tcf/Lef signaling mainly through a phosphatidylinositol 3-kinase-dependent pathway. This is the first indication of a fundamental difference in the signaling potential of EP(2) and EP(4) prostanoid receptors.

Citing Articles

Blockade of EP4 by ASP7657 Modulates Myeloid Cell Differentiation In Vivo and Enhances the Antitumor Effect of Radiotherapy.

Nishibata T, Amino N, Tanaka-Kado R, Tsujimoto S, Kawashima T, Konagai S Biomed Res Int. 2023; 2023:7133726.

PMID: 38058393 PMC: 10697779. DOI: 10.1155/2023/7133726.


Trinity of inflammation, innate immune cells and cross-talk of signalling pathways in tumour microenvironment.

Attiq A, Afzal S Front Pharmacol. 2023; 14:1255727.

PMID: 37680708 PMC: 10482416. DOI: 10.3389/fphar.2023.1255727.


PGE2 Produced by Exogenous MSCs Promotes Immunoregulation in ARDS Induced by Highly Pathogenic Influenza A through Activation of the Wnt-β-Catenin Signaling Pathway.

Yudhawati R, Shimizu K Int J Mol Sci. 2023; 24(8).

PMID: 37108459 PMC: 10138595. DOI: 10.3390/ijms24087299.


Prostaglandin E mediates the late phase of ischemic preconditioning in the heart via its receptor subtype EP.

Kanno T, Nakagawa N, Aonuma T, Kawabe J, Yuhki K, Takehara N Heart Vessels. 2022; 38(4):606-613.

PMID: 36522555 PMC: 9986202. DOI: 10.1007/s00380-022-02219-4.


Genome-wide association analysis of milk production, somatic cell score, and body conformation traits in Holstein cows.

Wang P, Li X, Zhu Y, Wei J, Zhang C, Kong Q Front Vet Sci. 2022; 9:932034.

PMID: 36268046 PMC: 9578681. DOI: 10.3389/fvets.2022.932034.